Real World Evidence (RWE) 101 – Non-Interventional Studies vs Market Health Research
Key differences between a non-interventional study (NIS) and market health research include:
1. Research Objective: NIS are conducted to examine real-world data and generate evidence on the effectiveness, safety, and outcomes of healthcare interventions in clinical settings. Market health research focuses on understanding market dynamics, consumer behavior, and market trends related to healthcare products or services.
3. Participants: NIS involve patients, healthcare providers, or healthcare institutions as participants, with the goal of studying healthcare interventions and their impact. Market health research focuses on consumers, stakeholders, and market entities, aiming to understand their preferences, attitudes, and behaviors related to healthcare products or services.
4. Methodology: NIS employ observational study designs, analyzing existing data or prospectively collecting data without actively intervening or manipulating variables. Market health research typically involves surveys, interviews, focus groups, or other market research techniques to gather specific information from targeted populations or market segments.
5. Data Collection: NIS gather clinical and patient-related data, such as treatment outcomes, adverse events, medical records, or registries, to assess the real-world impact of healthcare interventions. Market health research collects data on consumer perceptions, attitudes, preferences, purchasing behaviors, or market trends related to healthcare products or services.
6. Ethical Considerations: NIS are subject to research ethics guidelines and regulations, ensuring participant privacy, informed consent, and data confidentiality. Market health research also follows ethical guidelines, focusing on obtaining voluntary participation, ensuring data privacy, and protecting personal information.
7. Stakeholders: NIS primarily involve healthcare providers, researchers, and patients, aiming to inform clinical decision-making and healthcare policies. Market health research involves a broader range of stakeholders, including consumers, healthcare organizations, manufacturers, payers, and policymakers, with the goal of informing marketing strategies, product development, or policy decisions.
8. Reporting and Dissemination: NIS findings are typically reported in scientific journals, presented at medical conferences, or used to inform healthcare guidelines and policies. Market health research findings are often shared through market research reports, industry publications, or utilized internally for strategic decision-making within organizations.
While non-interventional studies and market health research have different objectives and methodologies, they can complement each other by providing a comprehensive understanding of healthcare interventions, their real-world impact, and the market dynamics surrounding healthcare products and services.
Share this story...
Real World Evidence (RWE) 101 – ICH GCP (R3) – Real World Evidence Context
RWE 101 - ICH GCP (R3) - Real World Evidence Context Revision 2 of ICH GCP caused confusion to those of us who work with non-interventional studies. The glossary [...]
Real World Evidence (RWE) 101 – Non-Interventional Studies vs Market Health Research
RWE 101 - Non-Interventional Studies vs Market Health Research Key differences between a non-interventional study (NIS) and market health research include:1. Research Objective: NIS are conducted to examine real-world [...]
Real World Evidence (RWE) 101 – Real World Evidence (RWE) 101 – Audits vs Inspections
RWE 101 - Real World Evidence (RWE) 101 - Audits vs Inspections In the context of regulatory compliance for Real-World Evidence (RWE), both audits and inspections play crucial roles, [...]
Real World Evidence (RWE) 101 – A Career of Many Pathways
RWE 101 - A Career of Many Pathways Real-world evidence (RWE) refers to the information on health care that is derived from analysis of real-world data (RWD). RWE [...]
Real World Evidence (RWE) 101 – Evolution of Regulatory Affairs
RWE 101 - Evolution of Regulatory Affairs Real-world evidence (RWE) and real-world data (RWD) are increasingly influencing regulatory affairs in the biopharmaceutical and healthcare industry. This change has been [...]
Real World Evidence (RWE) 101 – Project Managers
RWE 101 - Project Managers Real-World Evidence (RWE) observational studies and clinical trials are both key elements of medical research, but they involve very different methodologies, aims, and requirements. [...]